AbbVie and Calibr Announce Strategic Collaboration to Advance Preclinical Research
AbbVie (NYSE: ABBV) and US-based Calibr, the nonprofit drug discovery division of San Diego research...
Calibr
ArkBio and Calibr Renew Collaboration to Develop First-in-Class Respiratory Drug AK0705
Shanghai Ark Biopharmaceutical Co., Ltd announced that it has renewed its co-development collaboration with Calibr,...